However, the analysis of single TRB CDR3 sequences revealed the absence of specific clonotypic expansions at PML development, because the most expanded clones found at the time of PML were already present before natalizumab initiation and during therapy. The gene discussed is THRB; the disease is progressive multifocal leukoencephalopathy.